Goldman Sachs Small Cap Equity Insights Fund HALO Holdings History
Goldman Sachs Small Cap Equity Insights Fund's Halozyme Therapeutics Inc Holding Summary
As of 2025-04-30, GOLDMAN SACHS TRUST held - shares of Halozyme Therapeutics Inc(HALO), totaling N/A. This investment constitutes 0% of their stock portfolio, and GOLDMAN SACHS TRUST now holds 0% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2019Q4. And since then Goldman Sachs Small Cap Equity Insights Fund has made 8 purchases of HALO, at an average price of $29.41, for a total of 481,597.00 shares. In addition, there have been 8 sales at an average price of $31.17 for 481,597.00 shares. Based on historical transaction data and HALO's current price of $56.45, Goldman Sachs Small Cap Equity Insights Fund's estimated gain on his HALO holdings is $849,257.85, reflecting a 6.00% gain to date.
Goldman Sachs Small Cap Equity Insights Fund HALO ($56.45) Holding Chart
Goldman Sachs Small Cap Equity Insights Fund HALO ($56.45) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1